Founder & Managing Advisor
CurrentPatients and their families inspire everything we do. Our hospital and biotech experience informs how we do it. Founded by Maureen Dolan Bala in November 2020, Galway Group works with Biotech leaders to launch innovative therapies with maximum adherence, optimizing patient care and brand resources. We are an independent, woman-owned business.• Develop comprehensive Patient Access strategies across therapeutic areas: biosimilars, cell therapy, gene therapy, immunology, neurology, oncology, digital therapeutics, and ultra-rare.• Partner with Commercial leaders for launch excellence. Present to C-level, Board of Directors, and Investors. Communicate how Patient Support Program (PSP) strategies and tactics align with Brand pillars. Collaborate with Marketing to ensure consistent expectations for health care provider (HCP) uptake and Patient activation.• Assess Patient barriers and evaluate existing (competitor) programs by disease state. Identify and recommend non-promotional tactics that enable access and support persistence AFTER the Patient and HCP independently decide to prescribe.• Maximize client return on objective by collaborating with stakeholders to design and implement cost-effective solutions, improving Patient experience and access. Manage Request for Proposals (RFP) process for coverage and reimbursement, financial assistance, free products, and supplemental nurse education. Optimize existing PSP operations through performance monitoring, process improvements, and quality review coaching.
